Movado (MOV) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -21.05%. A quarter ago, it was expected that this watchmaker would post earnings of $0.31 per share when it actually produced earnings of $0.23, delivering a surprise of -25.81%.Over the last four quarters, the company has s ...

Central Garden (CENTA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +55.00%. A quarter ago, it was expected that this pet and lawn products maker would post earnings of $1.34 per share when it actually produced earnings of $1.56, delivering a surprise of +16.42%.Over the last four quarter ...

分组1 - Atkore Inc. reported quarterly earnings of $0.69 per share, missing the Zacks Consensus Estimate of $1.3 per share, and down from $2.43 per share a year ago, representing an earnings surprise of -46.92% [1] - The company posted revenues of $752.01 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.77%, but down from year-ago revenues of $788.3 million [2] - Atkore shares have lost about 20.3% since the beginning of the year, contrasting with the S&P 500's gain of 12.9% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.97 on revenues of $648.1 million, and for the current fiscal year, it is $5.41 on revenues of $2.84 billion [7] - The Wire and Cable Products industry, to which Atkore belongs, is currently in the top 37% of the Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - Cadiz reported a quarterly loss of $0.1 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.09, representing an earnings surprise of -11.11% [1] - The company posted revenues of $4.15 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 6.39%, and showing an increase from $3.22 million year-over-year [2] - Over the last four quarters, Cadiz has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] 分组2 - The stock has underperformed, losing about 11.5% since the beginning of the year, while the S&P 500 gained 16.5% [3] - The current consensus EPS estimate for the coming quarter is $0.54 on revenues of $3.9 million, and for the current fiscal year, it is $0.24 on revenues of $14.9 million [7] - The Agriculture - Operations industry, to which Cadiz belongs, is currently ranked in the bottom 21% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Insights - OmniAb, Inc. reported a quarterly loss of $0.14 per share, which aligns with the Zacks Consensus Estimate, showing an improvement from a loss of $0.16 per share a year ago [1] - The company's revenues for the quarter ended September 2025 were $2.24 million, missing the Zacks Consensus Estimate by 62.97% and down from $4.17 million year-over-year [2] - OmniAb's shares have declined approximately 58.2% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Financial Performance - The company has surpassed consensus EPS estimates only once in the last four quarters [1] - The current consensus EPS estimate for the upcoming quarter is -$0.15 on revenues of $7.15 million, and for the current fiscal year, it is -$0.59 on revenues of $21.52 million [7] Market Outlook - The earnings outlook and management's commentary during the earnings call will be crucial for assessing the stock's immediate price movement [3][4] - The Zacks Rank for OmniAb is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Medical - Drugs industry, to which OmniAb belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable environment for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

分组1 - Strattec Security reported quarterly earnings of $2.22 per share, exceeding the Zacks Consensus Estimate of $1.48 per share, and showing a significant increase from $0.92 per share a year ago, resulting in an earnings surprise of +50.00% [1] - The company achieved revenues of $152.4 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.14% and increasing from $139.05 million year-over-year [2] - Strattec Security has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] 分组2 - The stock has gained approximately 59.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 17.2% [3] - The company's earnings outlook is crucial for future stock performance, with current consensus EPS estimates of $0.99 for the upcoming quarter and $4.25 for the current fiscal year [7] - The Zacks Industry Rank places the Automotive - Original Equipment sector in the top 30% of over 250 Zacks industries, indicating a favorable environment for Strattec Security [8]

Core Insights - Weyerhaeuser reported quarterly earnings of $0.06 per share, exceeding the Zacks Consensus Estimate of a loss of $0.07 per share, and showing an increase from earnings of $0.05 per share a year ago, resulting in an earnings surprise of +185.71% [1] - The company achieved revenues of $1.72 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.12% and showing growth from $1.68 billion in the same quarter last year [2] - Weyerhaeuser shares have declined approximately 17.6% year-to-date, contrasting with the S&P 500's gain of 17.2% [3] Earnings Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is -$0.09 on revenues of $1.57 billion, while for the current fiscal year, the estimate is $0.08 on revenues of $6.87 billion [7] Industry Context - The Building Products - Wood industry, to which Weyerhaeuser belongs, is currently ranked in the bottom 8% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Weyerhaeuser's stock performance [5]

Core Insights - Insmed reported a quarterly loss of $1.75 per share, which was worse than the Zacks Consensus Estimate of a loss of $1.32, and compared to a loss of $1.27 per share a year ago [1][2] - The company achieved revenues of $142.34 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 24.16%, and up from $93.43 million year-over-year [3] - Insmed's stock has increased by approximately 141.8% since the beginning of the year, significantly outperforming the S&P 500's gain of 17.2% [4] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$1.16 on revenues of $154.71 million, and for the current fiscal year, it is -$5.55 on revenues of $469.57 million [8] - The estimate revisions trend for Insmed was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [7] Industry Context - Insmed operates within the Medical - Biomedical and Genetics industry, which is currently ranked in the top 38% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [9] - Another company in the same industry, Cue Biopharma, is expected to report a quarterly loss of $0.10 per share, reflecting a year-over-year change of +41.2%, with revenues projected to be $2.5 million, down 25.2% from the previous year [10]

Core Insights - Eagle Materials reported quarterly earnings of $4.23 per share, missing the Zacks Consensus Estimate of $4.35 per share, and showing a slight increase from $4.31 per share a year ago, resulting in an earnings surprise of -2.76% [1] - The company posted revenues of $638.91 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.96% and increasing from $623.62 million year-over-year [2] - Eagle Materials has underperformed the market with a 5.5% decline in share price since the beginning of the year, compared to a 17.2% gain in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $3.66 on revenues of $571.12 million, and for the current fiscal year, it is $13.99 on revenues of $2.32 billion [7] - The estimate revisions trend for Eagle Materials was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Building Products - Concrete and Aggregates industry, to which Eagle Materials belongs, is currently ranked in the top 22% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, Martin Marietta, is expected to report quarterly earnings of $6.65 per share, reflecting a year-over-year increase of 12.5%, with revenues projected at $2.05 billion, up 8.5% from the previous year [9][10]

Core Insights - RenaissanceRe (RNR) reported quarterly earnings of $15.62 per share, significantly exceeding the Zacks Consensus Estimate of $9.49 per share, marking an earnings surprise of +64.59% [1] - The company posted revenues of $2.87 billion for the quarter ended September 2025, which fell short of the Zacks Consensus Estimate by 3.67% and decreased from $3.01 billion year-over-year [2] - RenaissanceRe has surpassed consensus EPS estimates three times over the last four quarters, but has only topped revenue estimates once in the same period [2] Earnings Performance - The earnings report indicates a strong performance in terms of EPS, with a year-over-year increase from $10.23 to $15.62 per share [1] - The company had previously reported earnings of $12.29 per share against an expectation of $10.28, resulting in a surprise of +19.55% [1] Stock Performance and Outlook - RenaissanceRe shares have declined approximately 2.6% since the beginning of the year, contrasting with the S&P 500's gain of 16.9% [3] - The company's current Zacks Rank is 3 (Hold), suggesting that shares are expected to perform in line with the market in the near future [6] Future Earnings Expectations - The current consensus EPS estimate for the upcoming quarter is $7.34 on revenues of $2.92 billion, while the estimate for the current fiscal year is $28.11 on revenues of $11.87 billion [7] - The outlook for the industry, particularly the Insurance - Property and Casualty sector, is favorable, ranking in the top 14% of over 250 Zacks industries [8] Industry Context - The Insurance - Property and Casualty industry has shown strong performance, with the top 50% of Zacks-ranked industries outperforming the bottom 50% by a factor of more than 2 to 1 [8] - Berkshire Hathaway B (BRK.B), a competitor in the same industry, is expected to report quarterly earnings of $4.70 per share, reflecting a year-over-year change of +0.4% [9]